Fabienne Hermitte
Consigliere Generale presso VERACYTE, INC.
Posizioni attive di Fabienne Hermitte
Società | Posizione | Inizio | Fine |
---|---|---|---|
VERACYTE, INC. | Consigliere Generale | 01/08/2021 | - |
Storia della carriera di Fabienne Hermitte
Precedenti posizioni note di Fabienne Hermitte
Società | Posizione | Inizio | Fine |
---|---|---|---|
HalioDx SASU
HalioDx SASU BiotechnologyHealth Technology Part of HalioDxinvest SAS, HalioDx SASU is a French company that offers a comprehensive suite of biomarker services to deliver integrated and interpreted data, uncovering the critical biomarkers that drive effective decision-making. The company is based in Marseille, France. The company's services include outsourcing assays such as NGS, qPCR, ELISA, IHC, and IVD testing to Veracyte. The company also offers Immunogram, a service that integrates multi-omic data sets into a single per patient view of key biomarker signatures specific to their own TME. Additionally, Veracyte, a unique multiplex tissue imaging and analysis approach, combines multiple technologies to characterize the tumor microenvironment. The company was founded in 2014 by Vincent Fert, who has been the CEO since 2014. | Fondatore | 01/01/2015 | 01/08/2021 |
QIAGEN MARSEILLE | Direttore Tecnico/Scientifico/R&S | 23/09/1999 | - |
Fondatore | 07/07/2010 | - | |
Consigliere Generale | 23/09/1999 | - |
Formazione di Fabienne Hermitte
Institut de Formation Supérieure BioMédicale | Undergraduate Degree |
AgroParisTech | Doctorate Degree |
Faculté de Médecine Paris | Graduate Degree |
Statistiche
Distribuzione geografica
Francia | 6 |
Stati Uniti | 2 |
Posizioni
Founder | 2 |
General Counsel | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
VERACYTE, INC. | Health Technology |
Aziende private | 2 |
---|---|
QIAGEN Marseille SA
QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services QIAGEN Marseille SA is a molecular diagnosis company, which focuses on the development and marketing of diagnostic tests in the field of oncology. Its products are used for diagnosis, prognosis and monitoring of patients with leukemia. The company was founded by Vincent Fert, Stéphane Debono, and Fabienne Hermitte on September 23, 1999 and is headquartered in Marseille, France. | Commercial Services |
HalioDx SASU
HalioDx SASU BiotechnologyHealth Technology Part of HalioDxinvest SAS, HalioDx SASU is a French company that offers a comprehensive suite of biomarker services to deliver integrated and interpreted data, uncovering the critical biomarkers that drive effective decision-making. The company is based in Marseille, France. The company's services include outsourcing assays such as NGS, qPCR, ELISA, IHC, and IVD testing to Veracyte. The company also offers Immunogram, a service that integrates multi-omic data sets into a single per patient view of key biomarker signatures specific to their own TME. Additionally, Veracyte, a unique multiplex tissue imaging and analysis approach, combines multiple technologies to characterize the tumor microenvironment. The company was founded in 2014 by Vincent Fert, who has been the CEO since 2014. | Health Technology |
- Borsa valori
- Insiders
- Fabienne Hermitte
- Esperienza